Clinical trial
Screening Male BRCA Mutation Carriers: Effectiveness of Multispectral 3T Magnetic Resonance Imaging
NCT01990521 is registered in ClinicalTrials.gov with Toronto Sunnybrook Regional Cancer Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening Male BRCA Mutation Carriers: Effectiveness of Multispectral 3T Magnetic Resonance Imaging
- Lead sponsor
- Toronto Sunnybrook Regional Cancer Centre
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 31, 2014
- Completion date
- September 30, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer